PTPRC and myelodysplastic syndrome: Many of the conventional blast-counting methods do not account for the potential for abnormal blasts to mature along the monocyte or neutrophil lines, which may reduce the number of blasts observed in this CD45/SSC region and may even provide an inaccurate number for MDS diagnosis.